Journals in Cellular immunology

Autoimmunity Reviews

ISSN: 1568-9972
5 Year impact factor: 9.3
Impact factor: 9.2

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Cellular Immunology

ISSN: 0008-8749
5 Year impact factor: 4.1
Impact factor: 3.7

Cellular Immunology publishes original investigations concerned with the immunological activities of cells in experimental or clinical situations. The scope of the journal encompasses the broad area of in vitro and in vivo studies of cellular immune responses. Purely clinical descriptive studies are not considered.Research Areas include:• Antigen receptor sites • Autoimmunity • Delayed-type hypersensitivity or cellular immunity • Immunologic deficiency states and their reconstitution • Immunologic surveillance and tumor immunity • Immunomodulation • Immunotherapy • Lymphokines and cytokines • Nonantibody immunity • Parasite immunology • Resistance to intracellular microbial and viral infection • Thymus and lymphocyte immunobiology • Transplantation immunology • Tumor immunitySpecial issues: Suggestions for special issue topics and guest editors can be sent to Michael Cancro, [email protected] to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Current Opinion in Immunology

ISSN: 0952-7915
5 Year impact factor: 6.5
Impact factor: 6.6

Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Current Opinion in Immunology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Division of the subject into sections The subject of Immunology is divided into 8 themed sections and 2 special sections, each of which is reviewed once a year.Innate immunityTumour immunologyLymphocyte development and activationAntigen processingVaccinesAllergy and hypersensitivityHost pathogensAutoimmunitySelection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics. Review articles in Current Opinion in Immunology are by invitation only.Review Articles Authors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years.Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Immunology one of the most highly regarded and highly cited review journals in the field.

Developmental & Comparative Immunology

ISSN: 0145-305X
5 Year impact factor: 2.8
Impact factor: 2.7

Ontogeny, Phylogeny, AgingThe Official Journal of the International Society of Developmental and Comparative Immunology Developmental and Comparative Immunology (DCI) is an international journal that publishes articles describing original research in all areas of immunology, including comparative aspects of immunity and the evolution and development of the immune system of vertebrates and invertebrates. All levels of immunological investigations are appropriate: organismal, biochemical, cellular, and molecular. The Co-Editors-in-Chief particularly encourage submission of manuscripts that address mechanistic and functional aspects of immunity.Developmental and Comparative Immunology is the companion title to the open access journal Comparative Immunology Reports

European Journal of Cell Biology

ISSN: 0171-9335
5 Year impact factor: 5.4
Impact factor: 4.5

Announcement: Since January 2021 the European Journal of Cell Biology became an open access journal. Authors who publish in European Journal of Cell Biology will be able to make their work immediately, permanently, and freely accessible.European Journal of Cell Biology authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work. The APC will be requested after peer review and acceptance. The APC payment will be required for all accepted articles submitted after the 30th of September 2020. The European Journal of Cell Biology (EJCB) welcomes articles that include original long- and short-format studies and reviews covering multi-disciplinary approaches to cell biology in models as diverse as life itself. With emphasis in quality and reproducibility, the Journal also welcomes submissions on transversal and technical advances that push the edge of knowledge forward. The fundamental aim of EJCB is to serve its audience as a platform to illuminate and communicate the inner works of cells as the basic unit of life in its many shapes and forms.Cell biology has become a multidisciplinary science driven to understand the basic principles of cellular behavior from single molecules to whole tissues and organisms. Within this scope, EJCB includes studies in the following areas and beyond:Cell-cell and cell-matrix adhesionCell motility and migrationOrganelle dynamicsCell biophysics and mechanicsMolecular mechanobiologyCytoskeletal dynamicsCell proliferationCellular metabolismSignal transductionMolecular sortingCellular differentiation and reprogrammingCellular senescence and programmed cell deathCell specializationTechnical advances in cell biologyIn silico modelling of cell functions

Experimental Gerontology

ISSN: 0531-5565
5 Year impact factor: 3.8
Impact factor: 3.3

Experimental Gerontology is a multidisciplinary journal that spans all areas of gerontology, geroscience, and geriatrics, with an emphasis on studies focused on immune, endocrine, cellular, and subcellular systems, as well as studies focused on population-based, epidemiological, and basic aspects of age-related diseases, and interventional studies. The journal also publishes studies exploring functional, motor, cognitive, behavioral, and social implications of aging. Studies aimed at bridging the gap between mechanistic and clinical aspects of gerontology, such as papers on determinants of age-related conditions oriented toward the identification and validation of their biomarkers, are highly welcomed. Clinical case reports do not fall within the scope of the journal.Experimental Gerontology publishes original research, short reports, reviews and mini-reviews. Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews and original articles around a particular topic are also published in the journal. Suggestions for Special Issues can be made to the Editor-in-Chief, Editorial Board Members and editorial office.

FEBS Letters

ISSN: 0014-5793

FEBS Letters is one of the world's leading journals in biochemistry and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, hypotheses and research letters that merit urgent publication.FEBS Letters offers: • Faster publication: − Accepted articles are published online in 3 days − The print version of the article is published in 3 to 5 weeks after acceptance • Full-text article disclosure in HTML and PDF formats • Articles in Press are included in PubMed • Easy online manuscript submission system • Transparent online peer review and manuscript tracking system • No page charges • Free color figuresSubject Coverage: The subject area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism, and immunochemistry), structural biology, biophysics, computational biology (genomics, proteomics, bioinformatics), molecular genetics, molecular biology and molecular cell biology (signal transduction, intracellular traffic, regulation of cellular proliferation, cell-cell interactions) and systems biology. Studies on microbes, plants and animals at the molecular level are within the scope of FEBS Letters.Submitting Authors: Manuscripts can be submitted to FEBS Letters at: http://ees.elsevier.com/febsletters/

Human Immunology

ISSN: 0198-8859
5 Year impact factor: 2.3
Impact factor: 3.1

Human Immunology publishes full-length, original, hypothesis-driven basic and clinical research articles as well as brief communications, reviews and editorials covering immunogenetics, transplantation immunology, autoimmunity, and immunity to infectious diseases in humans. It also publishes short population reports, which are tied to the allelefrequencies.net database, describing allele frequencies of HLA and KIR.The journal's scope includes understanding the genetic and functional mechanisms that distinguish human individuals in their immune responses to allografts, pregnancy, infections or vaccines as well as the immune responses that lead to autoimmunity, allergy or drug hypersensitivity. It also includes examining the distribution of the genes controlling these responses in populations.Research areas include: • Studies of the genetics, genomics, polymorphism, evolution, and population distribution of immune-related genes • Studies of the expression, structure and function of the products of immune-related genes • Immunogenetics of susceptibility to infectious and autoimmune disease, and allergy • The role of the immune-related genes in hematopoietic stem cell, solid organ, and vascularized composite allograft transplant • Histocompatibility studies including alloantibodies, epitope definition, and T cell alloreactivity • Studies of immunologic tolerance and pregnancy • T cell, B cell, NK and regulatory cell functions, particularly related to subjects within the journal's scope • Pharmacogenomics and vaccine development in the context of immune-related genesHuman Immunology considers immune-related genes to include those encoding classical and non-classical HLA, KIR, MIC, minor histocompatibility antigens (mHAg), immunoglobulins, TCR, BCR, proteins involved in antigen processing and presentation, complement, Fc receptors, chemokines and cytokines. Other immune-related genes may be considered.Human Immunology is also interested in bioinformatics of immune-related genes and organizational topics impacting laboratory processes, organ allocation, clinical strategies, and registries related to autoimmunity and transplantation.Original papers with new data will be given preference over uninvited reviews and meta- analyses.Original papers with new data will be given preference over uninvited reviews and meta- analyses. As the flagship scientific publication of the American Society for Histocompatibility and Immunogenetics (ASHI), Human Immunology is primarily directed to readers with an interest in histocompatibility, immunogenetics, transplantation, anthropology/population studies, HLA disease association and pharmacogenomics. These include basic and clinical scientists as well as histocompatibility laboratory professionals.

Immunology Letters

ISSN: 0165-2478
5 Year impact factor: 3.6
Impact factor: 3.3

Published by Elsevier as the official journal of the European Federation of Immunological Societies (EFIS), a member of the International Union of Immunological SocietiesImmunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular, cellular, and clinical immunology. As the official journal of the European Federation of Immunological Societies (EFIS), Immunology Letters supports international consortia of experts. The journal welcomes collaborative contributions dedicated to the state-of-the-art of immunology topics, as well as commentaries on those topics.Preference is given to papers of immediate importance to other investigators. Therefore, the essential criteria for publication are clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas are considered for publication provided they are based on solid experimental findings. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.

Journal of Allergy and Clinical Immunology

ISSN: 0091-6749
5 Year impact factor: 10.2
Impact factor: 11.4

Official Journal of the American Academy of Allergy, Asthma and ImmunologyThe Journal of Allergy and Clinical Immunology publishes high-impact, cutting-edge basic, clinical and translational research papers in Allergy, Asthma and Immunology. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. With an impact factor of 14.2, the journal ranks 1st of 38 in the Allergy category and 11th of 177 in the Immunology category in the 2022 Journal Citation Reports®, published by Clarivate.Authors are also welcome to submit to the journal's companion titles, The Journal of Allergy and Clinical Immunology: In Practice and the Gold Open Access title, The Journal of Allergy and Clinical Immunology: Global. For more information on the articles reviewed by JACI: In Practice and JACI: Global, please visit their respective websites which are linked here: www.jaci-inpractice.org www.jaci-global.org

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health